Table 2. Top three significant GO terms enriched in the individual lists of MG132-sensitive proteins.
Increase in S phase following MG132 treatment | ||
GO Term | p-value | Protein Count |
Signal complex assembly | 0.009 | 2 |
Cell migration | 0.011 | 3 |
Cellular macromolecular complex assembly | 0.014 | 3 |
Decrease in S phase following MG132 treatment | ||
GO Term | p-value | Protein Count |
Ribonucleoprotein complex biogenesis | 2.59e−10 | 17 |
Ribosome biogenesis | 1.57e−07 | 12 |
RNA processing | 3.09e−07 | 23 |
Increase in G2 phase following MG132 treatment | ||
GO Term | p-value | Protein Count |
Translational elongation | 5.44e−130 | 68 |
Ribosome biogenesis | 1.01e−14 | 16 |
Ribonucleoprotein complex biogenesis | 2.13e−13 | 17 |
Decrease in G2 phase following MG132 treatment | ||
GO Term | p-value | Protein Count |
Protein transport | 1.45e−05 | 20 |
Protein localization | 3.30e−05 | 21 |
mRNA processing | 7.03e−05 | 12 |